Monday, 16 Sep 2019

Autoimmune/Lupus

Date Typesort ascending Title Save
15 Oct 2015 Social Comparisons of 524 Lupus shows pts w/ malar rash onset have more SLE activity at 1 & 5 yrs than DLE or non-CLE pts. http://t.co/OBou6Os6nF
22 Jun 2016 Social Breast cancer patients who also have autoimmune disorders have reduced survival and worse outcomes https://t.co/U2hsLENZxa
30 Apr 2017 Social RT @DrRachelTate: MALT more common than diffuse B cell lymphoma in Sjogrens pts. A Baer, MD @RheumNow #SOTA2017 https://t.co/GnEuD3JULd
06 Nov 2017 Social RT @Lupusdoc: Changes in gut microbiome linked to active SLE nephritis @RheumNow #ACR17 #1786 https://t.co/aWlsbEfNOe
18 Dec 2017 Social Population-based study suggests an increased risk of Alzheimer’sdisease in Sjögren’s syndrome #arthritis #feedly https://t.co/eTuu100UkL
17 Apr 2018 Social Lupus care provided by a Lupus specialty vs General Rheumatology (GRC) shows LC w/ better quality measures [86% vs 70%] w/ better APL testing, DXA, steroid sparing , ACE inhibitor use Moderate correlation between the MDs #SLE patients and QM performance https://t.co/HeHZgkA0Gv
22 Jul 2018 Social Prevalence of Lupus has increased over 16 yrs; Canadian adminstrative claims data shows lupus 6x more common in women than men. From 2000–2015 incidence 4.43 per 100K population. 2015 prevalence was 90 per 100,000 https://t.co/BV3WhbGISd
30 Aug 2016 Social Dr. Langford: VTE is increased risk w/ active GPA, MPA or EGPA. However no current evidence attesting to need for automatic anticoagulation
06 Apr 2016 Social Morphea can be more than skin deep; MRI and biopsy proven thickening of fascia. https://t.co/4sTMKrSgS0
02 Nov 2015 Social Uncontrolled trial of Perfenidone (antifibrotic) gel in 12 pts w/ localized scleroderma shows major skin benefits https://t.co/b2myM0uZVv
08 Jul 2016 Social Majority of pediatric lupus w/ acute pancreatitis develop macrophage activation syndr w/ high mortality rate https://t.co/m6i4iWynmz
23 Jul 2015 Social Apremilast useful in lupus? 8pt open label trial in discoid LE showed significant skin improvement @ 85d (by CLASI) http://t.co/v7iCv5H7zq
28 Sep 2016 Social IL-6 inhibitor (PF-04236921) NOT effective in SLE;186 pts RCT- 3 doses same as placebo in SRI-4, BICLA responses https://t.co/xBc3D9ONH3
05 Dec 2016 Social Catastrophic antiphospholipid registry:500 pts, 30% SLE, death in 37%; renal 73%, lung 60%, half w/ CNS, heart, skin https://t.co/3fWqYlLZ4p
14 Apr 2017 Social Anabasum is a oral endocannabinoid-mimetic binds to CB2 receptor, will enter a phase III trial in Systemic sclerosis https://t.co/2qeDOA32bT
18 May 2017 Social 189 SLE pts F/U for 13yrs; 53-59% lower risk of CV events if on ASA &HCQ, but APL Ab+ or HTN incr CV risk 18 fold https://t.co/O5PAOjIyv3
03 Nov 2017 Social Comparison of familial and sporadic SLE - Photosensitivity, thrombocytopenia renal more in sporadic SLE. https://t.co/VgizQzN6xq
07 Nov 2017 Social RT @_connectedcare: ANA as a screening test is problematic given this low specificity. Leads to so much anxiety #ACR17 @RheumNow https://t.…
23 Jan 2018 Social Among 286 SLE from the NHS, 42% were dsDNA+ at diagnosis. Current smokers were more likely to be dsDNA+ (HR 1.86) & >10 Pk-yr hx had elevated dsDNA+ SLE risk (HR 1.60) https://t.co/0RSI7r3zWP
27 May 2018 Social RheumNow Wk in Review is up-- Hot news on CIRT, OP, MPO & what SLE will and wont do. Checkout podcast on iTUnes or here https://t.co/0vxHMCOfHD